Navigation Links
National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
Date:9/4/2007

RESTON, Va., Sept. 4 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) announced today a new strategic focus on evidence-based medicine (EBM) for health care decision making.

While NPC's overarching mission remains to sponsor and conduct scientific analyses of the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation, the focus on EBM represents a new priority for NPC. NPC will be reorganizing and hiring additional staff with the clinical, scientific, and methodological expertise necessary to the focus on EBM.

"NPC has always worked on behalf of the research-based pharmaceutical industry to anticipate pivotal issues, engage with stakeholders to shape workable solutions, and sponsor research to inform choices facing health care decision makers," said Joseph M. Mahady, President of Global Business for Wyeth Pharmaceuticals and NPC Board Chairman. "In prioritizing NPC's activities, the Board unanimously agreed that NPC should focus on evidenced-based coverage and access as the highest priority moving forward."

The new focus on EBM will build on NPC's history of working with researchers, patients, medical professionals, and payers, including employers and government officials. Recent NPC work on EBM has included engagement with the Institute of Medicine Roundtable on Evidence-Based Medicine, the Agency for Healthcare Research and Quality (AHRQ), and the Health Industry Forum. In pursuing its new focus on EBM, NPC will:

-- Facilitate dialogue between the pharmaceutical industry and other

stakeholders;

-- Create awareness and understanding of industry expertise and

perspectives on EBM; and

-- Participate with major stakeholders in the EBM policy debate and

the pursuit of solutions.

Coinciding with the announcement of the new strategic focus, NPC President Karen Williams has announced she will be leaving her current position. According to Mahady, Williams encouraged and guided the Board's adoption of EBM as the focus for NPC and advocated for the reorganization and a search for new leadership. "It's been a privilege to work with the Board and staff, and I'm proud of what we have accomplished," said Ms. Williams.

"Karen has been a terrific resource and leader to the pharmaceutical industry for much of her professional career, especially in her role as NPC's President for the last 11 years," Mahady said. "We will certainly miss her tremendous health policy experience and wisdom, her enthusiasm, drive, and leadership on behalf of NPC and its member companies." Williams has agreed to remain at the helm of NPC during the search for her successor in order to help assure a successful transition.

Mahady said NPC is working with the Washington, DC office of the executive search firm of Korn/Ferry International to direct the search for the next President of the organization. NPC is working with Boyden Executive Search Firm in Atlanta for other senior staff positions, including a Vice President of Clinical and Scientific Affairs and a Research Director.

NPC was established in 1953 and is supported by approximately 20 of the nation's major research-based pharmaceutical companies.

NPC Contact: Pat Adams 703-606-2365; padams@npcnow.com

Korn/Ferry Contact: Lorraine Lavet (202) 955-0943; lorraine.lavet@kornferry.com

Boyden Contact: Deborah Coogan Seltzer 770/618-7655; dseltzer@boyden.com


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. International community warns India on HIV situation
2. National Lung Study in the process
3. Indian Nationals with Foreign Medical Degrees can now practice in India
4. Key step forward on International Health Rules
5. ICMR along with other International Research organisation with drug development for Neglected Diseases
6. International Osteoporosis Research Centre To Be Started In India.
7. Hepatitis B Vaccine To Be Included In National Immunization Programme
8. Indian hospitals require International Accreditation
9. International Conference On Malaria - Laveran To Genomics
10. UK Govt Says On Course For National Chlamydia Screening
11. Delhi To Host International Women’s Congress From Nov 2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco Canales, ... services in their Napa Valley office. The technique utilizes the body’s own healing ... Canales and Dr. Furnas, are part of only a select few cosmetic surgeons ...
(Date:2/5/2016)... ... ... US Sports Camps , official operators of Nike Yoga Camps, announces ... training. ChildLight Yoga Studio is centrally situated in the picturesque New England city of ... founder Lisa Flynn expresses her excitement, “We are thrilled to be partnering with US ...
(Date:2/5/2016)... ... February 05, 2016 , ... Boar’s Head Brand®, one of ... for this weekend’s Big Game. Take the stress out of your party preparation – ... guests happy at every stage of the game. , “The key to hosting a ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... CitiDent, announces that it is now welcoming orthodontist, Dr. Amanda Cheng, to ... a complete range of oral health care, including general dentistry, cosmetic treatments, periodontics, ...
(Date:2/5/2016)... ... February 05, 2016 , ... On June 9-10, Las ... continuing medical education (CME) event presented by the Association for Comprehensive Care in ... for ACCORD, whose mission is to provide education, tools, and resources to primary ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , February 5, 2016 Site ... Today, VoicePower Ltd - The Speech Recognition People, announced their latest ... to improve patient care, reduce turnaround times and to save the ... ,- VoicePower client since 2013 Challenge: --> ... --> - Six doctors ,- Wirral CCG ,- VoicePower ...
(Date:2/4/2016)... , Feb. 4, 2016  Edwards Lifesciences Corporation (NYSE: ... for structural heart disease and critical care monitoring, announced ... repurchase (ASR) agreement with Morgan Stanley & Co. LLC ... repurchase is part of the Company,s previously authorized program ... common stock.  --> ...
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
Breaking Medicine Technology: